December 15, 2021
UC Berkeley is partnering with UC San Francisco and Stanford University as founding scientific members of a new institute that aims to accelerate breakthroughs in complex diseases. The Arc Institute was officially launched today (Dec. 15) with the goal of developing a new model for collaborative research that brings together world-class research with unconstrained funding…
December 14, 2021
Graduate student Leah Gulyas explores how one tiny coronavirus protein blockades host cells—and how a few simple changes can flip the script. Mission control! Mission control! Do you read me? While these lines might first bring to mind a movie scene of astronauts frantically trying to contact their home base following a disastrous event in…
December 08, 2021
The wait for UC Berkeley’s bold new home for research and innovation is nearly over. After two years of construction, the Bakar BioEnginuity Hub (BBH) is scheduled to open in February 2022.
December 06, 2021
The UC Berkeley group that invented the CRISPR-Cas9 genome editing technology nearly 10 years ago has found a way to add or modify genes within a community of many different species simultaneously, opening the door to what could be called “community editing.”
October 13, 2021
Graduate student John Berude highlights a new discovery from the Portnoy lab at UC Berkeley that helps scientists understand how food-borne pathogens know when they’ve reached their target.
September 07, 2021
UC Berkeley’s Ting Xu and her students have come up with one solution for the global problem of single-use plastics: embed enzymes in the plastic, so that once the bag or cup is no longer wanted, it will self-destruct with a little heat and water.
July 21, 2021
Chemical biologists in the Wenjun Zhang Lab at the University of California, Berkeley, have discovered compound mutanofactin-697. This compound is crucial in the development of cavities induced by Streptococcus mutans and may serve as a target in the prevention and treatment of dental caries.
June 23, 2021
The SARS-CoV-2 virus contains a gene that codes for a strange protein that could be a good target for drugs to fight COVID-19 and possibly other coronavirus infections, according to a new study from the University of California, Berkeley.